Dr. Liang Schweizer: Creating Targeted Antibodies in Single Cells

Antibodies are one line of adaptive immune response, responding to new antigens that may represent threats. Some types of immunotherapy exploit antibodies that can target specific cell types, like those that emerge in certain cancers. However, developing antibodies for specific targets can be challenging for a variety of technical reasons. Dr. Liang Schweizer from HiFiBio discusses her company's approach of creating custom antibodies in single cells that speed the drug discovery process.